Photo by Ron Bergeron, Morguefile.comA powerful new painkiller with no apparent side effects or addictive qualities, may now be only a year or two from the consumer market.

“This offers a major paradigm shift in the control of pain,” declares Dr. Simon Halegoua, Professor of Neurobiology & Behavior at Stony Brook University, who has identified a novel sodium ion channel involved in the transmission of pain.

Phase II Clinical trials are currently underway in England and Canada.

(READ the story in ScienceDaily)


Photo by Ron Bergeron,

Leave a Reply